• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Metab Res Rev . Increased Risk of Type 1 Diabetes in Boys Under the Age of 5 Years During COVID-19 Lockdowns in Finland, Sweden and Stanfo

tetano

Editor, Senior Moderator
Diabetes Metab Res Rev


. 2025 Sep;41(6):e70084.
doi: 10.1002/dmrr.70084. Increased Risk of Type 1 Diabetes in Boys Under the Age of 5 Years During COVID-19 Lockdowns in Finland, Sweden and Stanford, CA, USA-An Observational Multicenter Study

Susanna Tall[SUP] 1 2 [/SUP], Priya Prahalad[SUP] 3 4 [/SUP], Martin Adiels[SUP] 5 6 7 [/SUP], Annika Rosengren[SUP] 5 6 [/SUP], Suvi M Virtanen[SUP] 2 8 9 [/SUP], David M Maahs[SUP] 3 4 [/SUP], Mikael Knip[SUP] 1 10 11 [/SUP]



Affiliations
Abstract

Aims: The COVID-19 pandemic has been associated with an increased incidence of type 1 diabetes. Changes in the type 1 diabetes incidences in countries like Sweden where very mild COVID-19 pandemic related measures were applied have not been established so far. We analysed the incidence of type 1 diabetes during the COVID-19 lockdown and before the lockdown in Sweden, Finland and Stanford, CA, USA.
Materials and methods: Type 1 diabetes incidence rates during the first 18 months of the SARS-CoV-2 pandemic (3/2020-8/2021) were compared to a period before the pandemic (three corresponding 18-month terms 2014-2019) in Sweden, Finland and Stanford.
Results: In Sweden, type 1 diabetes incidence increased by 5% (IRR 1.05; 95% CI = 0.98-1.12; p = 0.18, N = 4458), in Finland by 17% (IRR 1.17; 95% CI = 1.07-1.27; p < 0.001, N = 2881) and in Stanford by 10% (IRR = 1.10; 95% CI = 0.91-1.34; p = 0.34, N = 531) during the lockdown compared to the time before lockdown. In boys under 5 years of age, the incidence increased significantly in all regions: Sweden (IRR 1.21; 95% CI = 1.00-1.46; p = 0.05, N = 521), Finland (IRR = 1.33; 95% Cl = 1.06-1.67, p = 0.02, N = 363) and Stanford CA, USA (IRR = 2.07"; 95% Cl = 1.06-4.02, p = 0.03, N = 37).
Conclusions: Lockdowns during the COVID-19 pandemic may have untoward consequences such as an increased risk of type 1 diabetes in young children, boys in particular. The hygiene hypothesis may explain this finding.

Keywords: COVID‐19 pandemic; SARS‐CoV‐2; incidence; lockdown; type 1 diabetes.

 
Back
Top Bottom